Source: Pediatric Blood and Cancer. Conference titles: Congress of the International Society of Paediatric Oncology (SIOP). Unidade: FMRP
Subjects: MEDULOBLASTOMA, ANTINEOPLÁSICOS
ABNT
ANDRADE, A. F. et al. Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 23 maio 2024. , 2014APA
Andrade, A. F., Borges, K. S., Suazo, V. K., Castro-Gamero, A. M., Scrideli, C. A., & Tone, L. G. (2014). Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells. Pediatric Blood and Cancer. Hoboken: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.NLM
Andrade AF, Borges KS, Suazo VK, Castro-Gamero AM, Scrideli CA, Tone LG. Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells. Pediatric Blood and Cancer. 2014 ; 61 S338.[citado 2024 maio 23 ]Vancouver
Andrade AF, Borges KS, Suazo VK, Castro-Gamero AM, Scrideli CA, Tone LG. Effects of zebularine alone or in combination with the histone deacetylase inhibitor SAHA on medulloblastoma cells. Pediatric Blood and Cancer. 2014 ; 61 S338.[citado 2024 maio 23 ]